OmicsBank Raises $2.25M Seed

OmicsBank, based in San Francisco, is a clinical data infrastructure company that connects fragmented hospital data to support drug development and healthcare AI. The company has raised $2.25 million in a seed funding round.

Investors

This round was funded by Redesign Health, a global venture capital and technology firm.

OmicsBank Use of Funds

OmicsBank intends to use the capital to fuel its U.S. expansion across health systems, pharmaceutical firms, biotechnology companies, and AI developers. The funding will also support the growth of its clinical data network in Asia and the Middle East, as well as the development of GPU-enabled research environments for AI model training and computational biology research.

About OmicsBank

Founded in 2025 by Sumit Sinha and Vijay Goel, OmicsBank provides a platform that turns fragmented, unstructured clinical records into standardized, de-identified, patient-level datasets. The company mission is to bridge the gap in global representation within medical research and AI development by making biological and clinical data from diverse populations accessible for research.

Funding Details

Company Website: https://omicsbank.com

Company: OmicsBank
Raised: $2.25M
Round: Seed
Funding Date: August 25, 2026
Lead Investor: Redesign Health
Company Website: omicsbank.com
Software Category: Healthcare/AI
Source: https://www.prnewswire.com/news-releases/omicsbank-raises-2-25m-to-expand-clinical-data-infrastructure-globally-for-healthcare-life-sciences-and-frontier-ai-labs-302859623.html